Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 9 Motor Activity 9 Breast Neoplasms 7 Malnutrition 5 Head and Neck Neoplasms 4 Pancreatic Neoplasms 3 Laryngeal Neoplasms 3 Colonic Neoplasms 3 Stomach Neoplasms 2 Prostatic Neoplasms 2 Pharyngeal Neoplasms 2 Obesity 2 Lung Neoplasms 2 Liver Neoplasms 2 Diabetes Mellitus, Type 2 2 Colorectal Neoplasms 2 Ascites 2 Weight Loss 1 Undefined 1 Skin Neoplasms 1 Sarcopenia 1 Rectal Neoplasms 1 Psychological Well-Being 1 Pancreatitis, Chronic 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neurotoxicity Syndromes 1 Mouth Neoplasms 1 Lung Diseases 1 Liver Diseases 1

Interventions

pembrolizumab 24 Nivolumab 23 aldesleukin 21 Cyclophosphamide 20 Ipilimumab 17 Interleukin-2 17 fludarabine 15 fludarabine phosphate 14 cemiplimab 12 Radiotherapy 7 Fluorouracil 7 Biopsy 7 dabrafenib 6 Surveys and Questionnaires 6 Dacarbazine 6 trametinib 5 binimetinib 5 Vemurafenib 5 Temozolomide 5 Surgical Procedures, Operative 5 Sirolimus 5 Radiation 5 Blood Specimen Collection 5 Aminolevulinic Acid 5 sonidegib 4 encorafenib 4 Photochemotherapy 4 Mohs Surgery 4 HhAntag691 4 Educational Status 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Skin Neoplasms × Nutritional Status × Clear all

NCT05389332 2025-12-16

A Mobile Health Intervention Among Hispanics

Rutgers, The State University of New Jersey

Phase NA Recruiting

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡